Skip to main content

Want a detailed portfolio tracker?

Nuvalent (NUVL) P/E (2021 - 2026)

Nuvalent (NUVL) P/E from Sep 30, 2021 to Jul 16, 2026. The TTM Nuvalent (NUVL) P/E is -21.92. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Nuvalent (NUVL)

YearP/EChange
2026-21.92+20.95%
2025-18.13-20.07%
2024-22.68-39.83%
2023-37.69+94.99%
2022-19.33-60.65%
2021-49.12N/A

Comparison Nuvalent (NUVL) P/E with competitors

Nuvalent (NUVL) P/E is -21.92.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.34%
FGENFibroGen Inc0.24-101.09%
CHRSCoherus Biosciences Inc0.85-103.87%
FBIOFortress Biotech Inc0.95-104.33%
ORMPOramed Pharmaceuticals Inc1.50-106.86%
AGENAgenus Inc3.01-113.73%
INVAInnoviva Inc3.15-114.39%
VXRTVaxart Inc3.55-116.19%
CRMDCorMedix Inc3.63-116.55%
CVACCureVac N.V.4.45-120.28%
GLPGGalapagos NV4.86-122.16%
SRPTSarepta Therapeutics Inc4.88-122.27%
ABEOAbeona Therapeutics Inc5.39-124.57%
ABUSArbutus Biopharma Corp5.60-125.52%
ZVRAZevra Therapeutics Inc5.89-126.85%
SPROSpero Therapeutics Inc6.23-128.41%
CGENCompugen Ltd6.31-128.80%
RIGLRigel Pharmaceuticals6.87-131.35%
SLXNSilexion Therapeutics Corp7.30-133.28%
OMEROmeros Corporation9.26-142.23%
AUPHAurinia Pharmaceuticals Inc9.58-143.72%
PLXProtalix BioTherapeutics Inc10.89-149.68%
ACADAcadia Pharmaceuticals Inc11.73-153.50%
TBPHTheravance Biopharma Inc12.26-155.93%
ADMAAdma Biologics Inc12.42-156.64%
HRMYHarmony Biosciences Holdings Inc13.82-163.04%
SABSSAB Biotherapeutics Inc14.14-164.48%
NAGENiagen Bioscience Inc14.82-167.59%
INCYIncyte Corp15.82-172.17%
REGNRegeneron Pharmaceuticals Inc15.86-172.33%
PBYIPuma Biotechnology Inc17.32-178.98%
CPRXCatalyst Pharmaceuticals Inc17.44-179.55%
EXELExelixis Inc17.54-180.00%
TGTXTG Therapeutics Inc18.97-186.51%
MDXGMimedx Group Inc20.55-193.75%
XOMAXOMA Royalty Corp22.87-204.34%
ARGXArgen X SE24.30-210.83%
CTMXCytomX Therapeutics Inc24.82-213.22%
XOMAOXOMA Royalty Corp25.34-215.61%
HALOHalozyme Therapeutics Inc25.62-216.88%
XOMAPXOMA Royalty Corp25.67-217.09%
VRTXVertex Pharmaceuticals Inc27.99-227.70%
RPRXRoyalty Pharma plc - Class A28.69-230.86%
SLNOSoleno Therapeutics Inc29.02-232.35%
ASNDAscendis Pharma A/S30.09-237.23%
LGNDLigand Pharmaceuticals Inc - Class B37.91-272.93%
APLSApellis Pharmaceuticals Inc39.02-277.99%
BMRNBiomarin Pharmaceutical Inc42.21-292.55%
KRYSKrystal Biotech Inc45.34-306.83%
ONCBeiGene Ltd69.54-417.21%
PHARPharming Group N.V.75.03-442.23%
TECHBio-Techne Corp101.96-565.08%
VCELVericel Corp109.92-601.40%
ALNYAlnylam Pharmaceuticals Inc117.96-638.10%
GMABGenmab140.29-739.93%
TLXTelix Pharmaceuticals Ltd162.15-839.66%
CORTCorcept Therapeutics Inc212.86-1070.95%